The Washington Times

Topic - Janssen Pharmaceuticals Inc.

Subscribe to this topic via RSS or ATOM
Related Stories
  • Arkansas judge to decide penalty in J&J trial

    A judge will decide how much a Johnson & Johnson and a subsidiary must pay the state of Arkansas, after a jury found the company downplayed and hid risks associated with an antipsychotic drug.

  • Ark. judge fines Johnson & Johnson $1.1B in Risperdal case

    An Arkansas judge has fined Johnson & Johnson and a subsidiary more than $1.1 billion after a jury found that the companies downplayed and hid risks associated with an antipsychotic drug.

  • Arkansas judge fines J&J $1.1B in Risperdal case

    An Arkansas judge has fined Johnson & Johnson and a subsidiary more than $1.1 billion after a jury found the companies downplayed and hid risks associated with an antipsychotic drug.

  • Johnson & Johnson settles Texas lawsuit for $158M

    Texas and a subsidiary of health care giant Johnson & Johnson reached a $158 million settlement in a Medicaid fraud lawsuit Thursday, allowing the drugmaker to pay a fraction of the potential $1 billion in penalties and fines that state officials had initially sought.

More Stories →

Happening Now